Page 35 - Read Online

Page 16 of 24 Tokuyasu et al. J Cancer Metastasis Treat 2018;4:2 I http://dx.doi.org/10.20517/2394-4722.2017.52

Manuscript writing: Tokuyasu TA
Manuscript editing: Huang JD
Read and approved the final manuscript: Tokuyasu TA, Huang JD

Financial support and sponsorship
This work was supported by a National Basic Research Program of China (973 Program, No. 2014CB745202);
the Shenzhen Peacock Team Project (No. KQTD2015033117210153); the Shenzhen Science and
Technology Innovation Committee Basic Science Research Grants (No. JCYJ20170413154523577; No.
JCYJ20150629151046896); the Guangdong Natural Science Funds for Distinguished Young Scholar Grant (No.
S2013050016987).

Conflicts of interest
There are no conflicts of interest.

Patient consent
Not applicable.

Ethics approval
Not applicable.

Copyright
© The Author(s) 2018.

REFERENCES
1. Coley WB. The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893. Clin
Orthop Relat Res 1991;(262):3-11.
2. Parish CR. Cancer immunotherapy: the past, the present and the future. Immunol Cell Biol 2003;81:106-13.
3. Riera Romo M, Pérez-Martínez D, Castillo Ferrer C. Innate immunity in vertebrates: an overview. Immunology 2016;148:125-39.
4. Litman GW, Rast JP, Fugmann SD. The origins of vertebrate adaptive immunity. Nat Rev Immunol 2010;10:543-53.
5. Xing Y, Hogquist KA. T-Cell tolerance: central and peripheral. Cold Spring Harb Perspect Biol 2012;4:a006957.
6. Whitton JL, editor. Antigen Presentation. Berlin, Heidelberg: Springer; 1998.
7. van Endert P, editor. Antigen Processing: Methods and Protocols. Totowa, NJ: Humana Press; 2013.
8. Roche PA, Furuta K. The ins and outs of MHC class II-mediated antigen processing and presentation. Nat Rev Immunol 2015;15:203-
16.
9. Shah DK. T-cell development in thymus. British Society for Immunology. Available from: https://www.immunology.org/public-
information/bitesized-immunology/immune-development/t-cell-development-in-thymus. [Last accessed on 29 Jul 2017]
10. Crespo J, Sun H, Welling TH, Tian Z, Zou W. T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment.
Curr Opin Immunol 2013;25:214-21.
11. Walker LSK, Sansom DM. Confusing signals: recent progress in CTLA-4 biology. Trends Immunol 2015;36:63-70.
12. Manz BN, Jackson BL, Petit RS, Dustin ML, Groves J. T-cell triggering thresholds are modulated by the number of antigen within
individual T-cell receptor clusters. Proc Natl Acad Sci U S A 2011;108:9089-94.
13. Reinherz EL. αβ TCR-mediated recognition: relevance to tumor-antigen discovery and cancer immunotherapy. Cancer Immunol Res
2015;3:305-12.
14. Meydan C, Otu HH, Sezerman OU. Prediction of peptides binding to MHC class I and II alleles by temporal motif mining. BMC
Bioinformatics 2013;14 Suppl 2:S13.
15. Di Santo JP. Natural killer cells: diversity in search of a niche. Nat Immunol 2008;9:473-5.
16. Marsh SGE, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Fernández-Viña M, Geraghty DE, Holdsworth R, Hurley
CK, Lau M, Lee KW, Mach B, Maiers M, Mayr WR, Müller CR, Parham P, Petersdorf EW, Sasazuki T, Strominger JL, Svejgaard A,
Terasaki PI, Tiercy JM, Trowsdale J. Nomenclature for factors of the HLA system, 2010. Tissue Antigens 2010;75:291-455.
17. Ghattaoraya GS, Dundar Y, González-Galarza FF, Maia MHT, Santos EJM, da Silva ALS, McCabe A, Middleton D, Alfirevic A,
Dickson R, Jones AR. A web resource for mining HLA associations with adverse drug reactions: HLA-ADR. Database (Oxford)
2016;2016:baw069.
18. Robinson J, Soormally AR, Hayhurst JD, Marsh SGE. The IPD-IMGT/HLA database -new developments in reporting HLA variation.
Hum Immunol 2016;77:233-7.
19. Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P. A direct estimate of the human αβ T cell receptor diversity.